Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on mkilan criteria: Correlation with histopathological findings

Investigative Radiology

Volumn 44, Issue 6, 2009, Pages 311-321

  Lee, Dong Ho ^a   Kim, Se Hyung ^a   Lee, Jeong Min ^a   Park, Hee Sun ^b   Lee, Jae Young ^a   Yi, Nam Joon ^a   Suh, Kyung Suk ^a   Jang, Ja June ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a  

^a Seoul National University Hospital   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

: MDCT; Dual contrast liver MRI; Livertransplantation; Milan criteria; SPIO enhanced MRI

Indexed keywords

GADOBENATE DIMEGLUMINE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HEPATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JACKKNIFE TEST; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY;

EID: 67651108825     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31819c9f44     Document Type: Article

References (40)

1. Mazzaferro V. Results of liver transplantation: with or without Milan criteria? Liver Transpl. 2007;13:S44-S47.
2. O'Grady JG, Polson RJ, Rolles K, et al. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg. 1988;207:373-379.
3. Ringe B, Wittekind C, Bechstein WO, et al. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg. 1989;209:88-98.
4. Haug CE, Jenkins RL, Rohrer RJ, et al. Liver transplantation for primary hepatic cancer. Transplantation. 1992;53:376-382.
5. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
6. Befeler AS, Hayashi PH, Di Bisceglie AM. Liver transplantation for hepatocellular carcinoma. Gastroenterology. 2005;128:1752-1764.
7. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394-1403.
8. Bhattacharjya S, Bhattacharjya T, Quaglia A, et al. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of preoperative imaging, explant histology and prognostic histologic indicators. Dig Surg. 2004;21:152-159.
9. Santoyo J, Suarez MA, Ferna'ndez-Aguilar JL, et al. Liver transplant results for hepatocellular carcinoma applying strict preoperative selection criteria. Transplant Proc. 2005;37:1488-1490.
10. Kim YK, Kim CS, Chung GH, et al. Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. Am J Roentgenol. 2006;186:149-157.
11. Chang JM, Lee JM, Lee MW, et al. Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging: comparison of 1. 5 T and 3.0 T imaging for detection of focal malignant liver lesions. Invest Radiol. 2006;41:168-174.
12. Kopp AF, Heuschmid M, Claussen CD. Multidetector helical CT of the liver for tumor detection and characterization. Eur Radiol. 2002;12:745-752.
13. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol. 2006;41:213-221.
14. Kreitner KF, Kunz RP, Herber S, et al. MR angiography of the pedal arteries with gadobenate dimeglumine, a contrast agent with increased relaxivity, and comparison with selective intraarterial DSA. J Magn Reson Imaging. 2008; 27:78-85.
15. Zech CJ, Grazioli L, Breuer J, et al. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPAenhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol. 2008;43:504-511.
16. Kim JI, Lee JM, Choi JY, et al. The value of gadobenate dimeglumineenhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol. 2008;43:202-210.
17. Tanimoto A, Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol. 2006;58:200-216.
18. Reimer P, Jähnke N, Fiebich M, et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxideenhanced MR imaging, and spiral CT-ROC analysis. Radiology. 2000;217: 152-158.
19. Kim MJ, Kim JH, Chung JJ, et al. Focal hepatic lesions: detection and characterization with combination gadolinium-and superparamagnetic iron oxide-enhanced MR imaging. Radiology. 2003;228:719-726.
20. Kim YK, Kwak HS, Kim CS, et al. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology. 2006;238:531-541.
21. Bhartia B, Ward J, Guthrie JA, et al. Hepatocellular carcinoma in cirrhotic livers: dual-contrast thin-section MR imaging with pathologic correlation of explanted tissue. Am J Roentgenol. 2003;180:577-584.
22. Kim YK, Kim CS, Kwak HS, et al. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging. J Magn Reson Imaging. 2004;20:826-837.
23. Krinsky GA, Lee VS, Theise ND, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explanation correlation. Radiology. 2001;219:445-454.
24. Pauleit D, Textor J, Bachmann R, et al. Hepatocellular carcinoma: detection with gadolinium-and ferumoxides-enhanced MR imaging of the liver. Radiology. 2002;222:73-80.
25. Peterson MS, Baron RL, Marsh JW Jr, et al. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology. 2000;217:743-749.
26. Rode A, Bancel B, Douek P, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr. 2001;25:327-336.
27. Tang Y, Yamashita Y, Arakawa A, et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium-and ferumoxidesenhanced MR imaging. Am J Roentgenol. 1999;172:1547-1554.
28. Ward J, Guthrie JA, Scott DJ, et al. Hepatocellular carcinoma in the cirrhotic liver: dual-contrast MR imaging for diagnosis. Radiology. 2000;216:154-162.
29. Kim SH, Choi BI, Lee JY, et al. Diagnostic accuracy of multi-/single-detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the milan criteria before liver transplantation. Intervirology. 2008;51(S):52-60.
30. Kim KW, Lee JM, Klotz E, et al. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma. Radiology.2009;250:425-434.
31. Chakraborty DP. Analysis of location specific observer performance data: validated extensions of the jackknife free-response (JAFROC) method. Acad Radiol. 2006;13:1187-1193.
32. Kim SH, Lee JM, Kim YJ, et al. Detection of hepatocellular carcinoma on CT in liver transplant candidates: comparison of PACS tile and multisynchronized stack modes. Am J Roentgenol. 2007;188:1337-1342.
33. Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005;42:27-34.
34. Elizondo G, Weissleder R, Stark DD, et al. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology. 1990; 174:797-801.
35. Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxideenhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology. 2000;32:205-212.
36. Yoo HJ, Lee JM, Lee MW, et al. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3. 0T-MR imaging with pathologic correlation. Invest Radiol. 2008;43:538-546.
37. Taouli B, Krinsky GA. Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation. Liver Transpl. 2006;12: S1-S7.
38. Krinsky G. Imaging of dysplastic nodules and small hepatocellular carcinomas: experience with explanted livers. Intervirology. 2004;47:191-198.
39. Jang HJ, Lim JH, Lee SJ, et al. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation? Radiology. 2000;215:373-380.
40. Brancatelli G, Baron RL, Peterson MS, et al. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. Am J Roentgenol. 2003;180:1007-1014.